Chinese enterprise to the distribution of COVID-19 vaccines established in the UK

By Bioethics Observatory|2020-09-18T13:23:05+02:00September 18th, 2020|Bioethics, BRIEF NEWS|0 Comments

View Larger Image

COVID-19 vaccines distribution a current bioethics problem. In this respect, a social enterprise has been established in the United Kingdom to promote the production and distribution of COVID-19 vaccines, to enable them to reach developing countries. The company, called VacEquity Global Health (VGH), proposes to “waive its royalties in order to reduce vaccine production costs”. The enterprise is supported by Morningside Ventures, a private entity founded by the Chan family of Hong Kong (read HERE)

About the Author: Bioethics Observatory

Our website includes “Special reports” and “News” based on the latest biomedical and biotechnological research findings from the world’s top medical and scientific journals, such as the biological and anthropological status of the human embryo, matters regarding the end of life, especially euthanasia, assisted suicide and palliative care, and also some of the issues that are currently giving rise to major debates, including assisted reproduction, surrogacy, use of contraceptives and the morning-after pill, transsexuality, genome editing, synthetic biology, production of human-animal chimeras for medical purposes and transhumanism. We publish monthly two newsletters Bioethics News and Bioethics at a Glance. More than 10.000 subscribers receive them.